-
The ASHP Foundation has announced that Evanston (IL) Northwestern Healthcare (ENH) has been awarded the 2005 Award for Excellence in Medication-Use Safety.
-
New research shows promising results in the use of mycophenolate mofetil (CellCept) to treat lupus without severe side effects associated with the current standard of care.
-
Falsely elevated glucose readings, warns FDA; FDA warning: Adverse events with rFVIIa; ASHP provides reference to Consumer Reports guide; FDA approves updated labeling for Lexiva; Red cell aplasia, severe anemia linked to drug
-
Deferasirox is the first orally administered medication to be approved for this use. Treatment for iron overload, which can damage the heart and liver, had previously required daily prolonged drug infusions lasting eight to 12 hours.
-
Ramelteon is indicated for the treatment of insomnia characterized by difficulty with sleep onset. The FDA approval allows physicians to prescribe ramelteon for long-term use in adults.
-
-
-
It can be a challenge to design a training program in human subjects protection that can meet all the needs of varied researchers from biomedical to social-behavioral disciplines, from introductory courses to advanced topics for experienced researchers.
-
One of the bigger headaches for IRBs is having to sift through hundreds or thousands of unanticipated problems submissions when most of these should never have been reported.
-
Amid growing concern that terrorists may strike with a nuclear weapon instead of a biological one, the government is fast-tracking programs to develop medical countermeasures against radiological and nuclear threats.
